Atomi Financial Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Atomi Financial Group's MRNA Position: Q2 2026 in Review
Atomi Financial Group reduced its Moderna (MRNA) stake by 7.8% in Q2 2026, selling an estimated $38.3K and leaving 8,776 shares worth $615K. The position accounts for 0.02% of the portfolio, ranked #677.
Atomi Financial Group first reported a position in MRNA in Q1 2024 and has held it in 4 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Atomi Financial Group held 8,776 shares of Moderna worth $615K as of Q2 2026.
- Atomi Financial Group sold 741 Moderna shares in Q2 2026, an estimated $38.3K.
- Moderna made up 0.02% of Atomi Financial Group's portfolio in Q2 2026, its #677 holding.
- Atomi Financial Group first reported a position in Moderna in Q1 2024 and has held it in 4 quarters since.
- 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.